AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2020
Dec 17, 2020
30786_dirs_2020-12-16_9e952b35-8e85-4f48-818d-d36fb931b89c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2020-12-04
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-04 | Bio-Rad B Common Stock | G | 27 | $.00 | Acquired | 298274 | Direct |
| 2020-12-04 | Bio-Rad B Common Stock | G | 27 | $.00 | Acquired | 12838 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 418971 | Direct |
| Bio-Rad B Common Stock | 4060054 | Indirect |
Footnotes
F1: The Form 4 is being amended only to add the reporting person's name on the signature line.
F2: The reporting person disclaims beneficial ownership of these shares.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13